 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
G9a-like protein lysine methyltransferase inhibition by bix- 01294
|
|
Structure:
|
 |
Histone-lysine n-methyltransferase, h3 lysine-9 specific 5. Chain: a, b. Fragment: unp residues 975-1235, set domain. Synonym: histone h3-k9 methyltransferase 5, h3-k9-hmtase 5, euchromatic histone-lysine n-methyltransferase 1, eu- hmtase1, g9a-like protein 1, glp1, lysine n- methyltransferase 1d. Engineered: yes
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: ehmt1, euhmtase1, kiaa1876, kmt1d. Expressed in: escherichia coli. Expression_system_taxid: 562.
|
|
Resolution:
|
 |
|
2.40Å
|
R-factor:
|
0.221
|
R-free:
|
0.262
|
|
|
Authors:
|
 |
Y.Chang,X.Zhang,J.R.Horton,X.Cheng
|
Key ref:
|
 |
Y.Chang
et al.
(2009).
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.
Nat Struct Biol,
16,
312-317.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
05-Jan-09
|
Release date:
|
17-Feb-09
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
Q9H9B1
(EHMT1_HUMAN) -
Histone-lysine N-methyltransferase EHMT1
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1298 a.a.
261 a.a.
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
PfamB domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.1.1.43
- Histone-lysine N-methyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
S-adenosyl-L-methionine + L-lysine-[histone] = S-adenosyl-L-homocysteine + N6-methyl-L-lysine-[histone]
|
 |
 |
 |
 |
 |
S-adenosyl-L-methionine
|
+
|
L-lysine-[histone]
|
=
|
S-adenosyl-L-homocysteine
Bound ligand (Het Group name = )
corresponds exactly
|
+
|
N(6)-methyl-L-lysine-[histone]
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
nucleus
|
1 term
|
 |
|
Biological process
|
chromatin modification
|
1 term
|
 |
|
Biochemical function
|
zinc ion binding
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Nat Struct Biol
16:312-317
(2009)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294.
|
|
Y.Chang,
X.Zhang,
J.R.Horton,
A.K.Upadhyay,
A.Spannhoff,
J.Liu,
J.P.Snyder,
M.T.Bedford,
X.Cheng.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Histone lysine methylation is an important epigenetic mark that regulates gene
expression and chromatin organization. G9a and G9a-like protein (GLP) are
euchromatin-associated methyltransferases that repress transcription by
methylating histone H3 Lys9. BIX-01294 was originally identified as a G9a
inhibitor during a chemical library screen of small molecules and has previously
been used in the generation of induced pluripotent stem cells. Here we present
the crystal structure of the catalytic SET domain of GLP in complex with
BIX-01294 and S-adenosyl-L-homocysteine. The inhibitor is bound in the substrate
peptide groove at the location where the histone H3 residues N-terminal to the
target lysine lie in the previously solved structure of the complex with histone
peptide. The inhibitor resembles the bound conformation of histone H3 Lys4 to
Arg8, and is positioned in place by residues specific for G9a and GLP through
specific interactions.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
(a) Progression of methylation as a function of reaction
time. The arrows point to the conditions used for subsequent
inhibition studies. (b) The inhibition on G9a and GLP by various
concentrations of BIX-01294. (c) Variation in the relative
abundance of each peptide species (me0, me1 and me2) as a
function of BIX-01294 concentration. (d) Ras-mediated epigenetic
silencing of Fas is derepressed with both BIX-01294 (BIX) and
5-aza treatments. (e) Methylation of DNMT1 by G9a and GLP and
inhibition by BIX-01294; the autoradiography image and relative
activity by TCA counts. Error bars in b, c and e indicate s.d.
for two duplicated measurements.
|
 |
Figure 2.
(a) Structure of the GLP SET domain. (b) AdoHcy and BIX-01294
bind in two distinctive pockets. (c,d) BIX-01294 binds in the
substrate peptide binding groove (c), which is occupied by
H3K4–H3R8 (d; PDB 2RFI^12). (e) Superimposition of H3 peptide
(yellow) and BIX-01294. (f) Water molecules (small red spheres)
occupy the target lysine binding channel.
|
 |
|
|
|
| |
The above figures are
reprinted
from an Open Access publication published by Macmillan Publishers Ltd:
Nat Struct Biol
(2009,
16,
312-317)
copyright 2009.
|
|
| |
Figures were
selected
by the author.
|
|
|
| |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
|
| |
In panel Figure 1e, the concentration of inhibitor is in uM (micro M).
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.K.Upadhyay,
and
X.Cheng
(2011).
Dynamics of histone lysine methylation: structures of methyl writers and erasers.
|
| |
Prog Drug Res, 67,
107-124.
|
 |
|
|
|
|
 |
K.Plath,
and
W.E.Lowry
(2011).
Progress in understanding reprogramming to the induced pluripotent state.
|
| |
Nat Rev Genet, 12,
253-265.
|
 |
|
|
|
|
 |
R.A.Varier,
and
H.T.Timmers
(2011).
Histone lysine methylation and demethylation pathways in cancer.
|
| |
Biochim Biophys Acta, 1815,
75-89.
|
 |
|
|
|
|
 |
S.Krishnan,
S.Horowitz,
and
R.C.Trievel
(2011).
Structure and function of histone H3 lysine 9 methyltransferases and demethylases.
|
| |
Chembiochem, 12,
254-263.
|
 |
|
|
|
|
 |
A.M.Quinn,
A.Allali-Hassani,
M.Vedadi,
and
A.Simeonov
(2010).
A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors.
|
| |
Mol Biosyst, 6,
782-788.
|
 |
|
|
|
|
 |
C.S.Beshara,
C.E.Jones,
K.D.Daze,
B.J.Lilgert,
and
F.Hof
(2010).
A simple calixarene recognizes post-translationally methylated lysine.
|
| |
Chembiochem, 11,
63-66.
|
 |
|
|
|
|
 |
H.Wu,
J.Min,
V.V.Lunin,
T.Antoshenko,
L.Dombrovski,
H.Zeng,
A.Allali-Hassani,
V.Campagna-Slater,
M.Vedadi,
C.H.Arrowsmith,
A.N.Plotnikov,
and
M.Schapira
(2010).
Structural biology of human H3K9 methyltransferases.
|
| |
PLoS One, 5,
e8570.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
I.Maze,
H.E.Covington,
D.M.Dietz,
Q.LaPlant,
W.Renthal,
S.J.Russo,
M.Mechanic,
E.Mouzon,
R.L.Neve,
S.J.Haggarty,
Y.Ren,
S.C.Sampath,
Y.L.Hurd,
P.Greengard,
A.Tarakhovsky,
A.Schaefer,
and
E.J.Nestler
(2010).
Essential role of the histone methyltransferase G9a in cocaine-induced plasticity.
|
| |
Science, 327,
213-216.
|
 |
|
|
|
|
 |
M.S.Cosgrove,
and
A.Patel
(2010).
Mixed lineage leukemia: a structure-function perspective of the MLL1 protein.
|
| |
FEBS J, 277,
1832-1842.
|
 |
|
|
|
|
 |
M.Sakurai,
N.R.Rose,
L.Schultz,
A.M.Quinn,
A.Jadhav,
S.S.Ng,
U.Oppermann,
C.J.Schofield,
and
A.Simeonov
(2010).
A miniaturized screen for inhibitors of Jumonji histone demethylases.
|
| |
Mol Biosyst, 6,
357-364.
|
 |
|
|
|
|
 |
M.Wang,
M.W.Mok,
H.Harper,
W.H.Lee,
J.Min,
S.Knapp,
U.Oppermann,
B.Marsden,
and
M.Schapira
(2010).
Structural genomics of histone tail recognition.
|
| |
Bioinformatics, 26,
2629-2630.
|
 |
|
|
|
|
 |
R.Collins,
and
X.Cheng
(2010).
A case study in cross-talk: the histone lysine methyltransferases G9a and GLP.
|
| |
Nucleic Acids Res, 38,
3503-3511.
|
 |
|
|
|
|
 |
T.J.Wigle,
L.M.Provencher,
J.L.Norris,
J.Jin,
P.J.Brown,
S.V.Frye,
and
W.P.Janzen
(2010).
Accessing protein methyltransferase and demethylase enzymology using microfluidic capillary electrophoresis.
|
| |
Chem Biol, 17,
695-704.
|
 |
|
|
|
|
 |
T.K.Kelly,
D.D.De Carvalho,
and
P.A.Jones
(2010).
Epigenetic modifications as therapeutic targets.
|
| |
Nat Biotechnol, 28,
1069-1078.
|
 |
|
|
|
|
 |
W.P.Janzen,
T.J.Wigle,
J.Jin,
and
S.V.Frye
(2010).
Epigenetics: Tools and Technologies.
|
| |
Drug Discov Today Technol, 7,
e59-e65.
|
 |
|
|
|
|
 |
X.Cheng,
and
R.M.Blumenthal
(2010).
Coordinated chromatin control: structural and functional linkage of DNA and histone methylation.
|
| |
Biochemistry, 49,
2999-3008.
|
 |
|
|
|
|
 |
F.Liu,
X.Chen,
A.Allali-Hassani,
A.M.Quinn,
G.A.Wasney,
A.Dong,
D.Barsyte,
I.Kozieradzki,
G.Senisterra,
I.Chau,
A.Siarheyeva,
D.B.Kireev,
A.Jadhav,
J.M.Herold,
S.V.Frye,
C.H.Arrowsmith,
P.J.Brown,
A.Simeonov,
M.Vedadi,
and
J.Jin
(2009).
Discovery of a 2,4-diamino-7-aminoalkoxyquinazoline as a potent and selective inhibitor of histone lysine methyltransferase G9a.
|
| |
J Med Chem, 52,
7950-7953.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Colin,
and
C.Van Lint
(2009).
Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies.
|
| |
Retrovirology, 6,
111.
|
 |
|
|
|
|
 |
R.A.Copeland,
M.E.Solomon,
and
V.M.Richon
(2009).
Protein methyltransferases as a target class for drug discovery.
|
| |
Nat Rev Drug Discov, 8,
724-732.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|